Rtant emerging treatment for neuropathic pain post SCI on account of its growing use amongst other pain populations. Future studies in to the use of other novel antidepressants may be expected to improve the therapeutic solutions accessible to individuals with neuropathic SCI pain. Acknowledgments The authors declare no conflicts of interest.REFERENCES 1. Cardenas DD, Felix ER. Discomfort after spinal cord injury: A evaluation of classification, therapy approaches, and treatment assessment. PM R. 2009;1:1077-1090. two. Demarin V, Basic-Kes V, Zavoreo I, et al. Ad hoc committee with the Croatian Society of Neurovascular Disorders, Croatian Health-related Association: Recommendations for neuropathic discomfort treatment. Acta Clin Croat. 2008;47:181-191. 3. Siddall PJ, Loeser JD. Discomfort following spinal cord injury. Spinal Cord. 2001;39:63-73. 4. Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T. Chronic neuropathic discomfort management in spinal cord injury sufferers. What is the efficacy of pharmacological treatments with a common mode of administration Ann Phys Rehabil Med. 2009;52:124-141. 5. Bryce TN, Ragnarsson KT. Pain just after spinal cord injury. Major Spinal Cord Injury Rehabil. 2000;11:157168. six. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic discomfort: Evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003;25:81-104. 7. Baastrup C, Finnerup NB. Pharmacological management of neuropathic discomfort following spinal cord injury. CNS Drugs. 2008;22:455-475. 8. Teasell RW, Mehta S, Aubut JL, et al; the Spinal Cord Rehabilitation Proof Research Group. A systematic review of pharmacologic treatments of pain soon after spinal cord injury. Arch Phys Med Rehabil. 2010;91:816-831. 9. Finnerup NB, Jensen TS. Spinal cord injury pain mechanisms and remedy. Eur J Neurol. 2004;11:73-82. 10. Ir ving GA. Contemporar y assessment and management of neuropathic pain. Neurology. 2005;64:S21-S27. 11. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the therapy of neuropathic discomfort. Fundamental Clin Pharmacol Toxicol. 2005;96:399-409. 12. Jadad AR, Moore RA, Carroll D, et al. Assessing the high quality of reports of randomized 282 clinical trials: Is blinding necessary Manage Clin Trials. 1996;17:1-12. 13. Cohen J. Statistical Energy Analysis for the Behavioral Sciences.1S,2S-DHAC-Phenyl Trost Ligand manufacturer 2nd ed.3-Hydroxy-2-methyl-Butanoic acid Order New York: Academic Press; 1988.PMID:24518703 14. Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: Outcomes of a randomized controlled trial. Pain. 2002;96:365373. 15. Davidoff G, Guarracini M, Roth E, Sliwa J, Yarkony G. Trazodone hydrochloride in the therapy of dysesthetic pain in traumatic myelopathy: AAntidepressants for Discomfort Just after SCI16.17.18. 19. 20.randomized, double-blind placebo-controlled study. Discomfort. 1987;29:151-161. Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison with the effectiveness of amitriptyline and gabapentin on chronic neuropathic discomfort in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88:1547-1560. Vranken JH, Hollmann MW, van der Vegt MH, et al. Duloxetine in patients with central neuropathic discomfort brought on by spinal cord injury or stroke: A randomized, double-blind, placebo-controlled trial. Discomfort. 2011;152:267-273. Chan HN, Fam J, Ng BY. Use of antidepressants inside the treatment of chronic pain. Ann Acad Med Singapore. 2009;38:974-979. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Systematic Rev. 2007;four:CD005454. Janzen S, Meht.
